首页> 外文期刊>Reproductive Biology and Endocrinology >Vitrification of human ovarian tissue: a practical and relevant alternative to slow freezing
【24h】

Vitrification of human ovarian tissue: a practical and relevant alternative to slow freezing

机译:人体卵巢组织玻璃化:慢速冷冻的实用且相关的替代方法

获取原文
           

摘要

Background Cryopreservation of ovarian tissue can be used to preserve the fertility of patients who are about to receive treatment(s) that could compromise their future ovarian function. Here we evaluate the effectiveness of a vitrification protocol by carrying out a systematic comparison with a conventional slow-freezing method on human ovarian tissue. Methods Human ovarian samples (mean age 28.0?±?1.1?years) were processed in parallel for each cryopreservation procedure: vitrification and slow-freezing. Following warming/thawing, histological observations and a TUNEL assay in ovarian follicles were performed and compared to unfrozen control. Results Both cryopreservation protocols gave comparable histological outcomes. Percentage of intact follicles was 83.6?% following vitrification in a 1.5?M 1,2-propanediol (PrOH), 1.5?M ethylene glycol (EG) and 0.5?M raffinose solution, 80.7?% after slow-freezing in 1.5?M PrOH and 0.025?M raffinose, and 99.6?% in fresh tissue. Follicle density was unchanged by vitrification (0.6 follicles/mm2) or slow-freezing (0.5 follicles/mm2) compared to fresh tissue (0.7 follicles/mm2). Percentage of follicles with DNA fragmentation was not statistically different in vitrified (20.8?%) or slow-frozen (31.3?%) tissues compared to the unfrozen control (35.0?%). There was no difference in proportion of stroma cells with DNA fragmentation in vitrified (6.4?%) and slow-frozen (3.7?%) tissues compared to unfrozen tissue (4.2?%). Conclusions This vitrification protocol enables good preservation of ovarian quality post-warming. The evaluation of endocrine function after vitrification need to be perform in a higher cohort to evaluate if this protocol may offer a relevant alternative to conventional slow-freezing for the cryopreservation of human ovarian tissue.
机译:背景技术卵巢组织的冷冻保存可用于保护即将接受可能损害其未来卵巢功能的治疗的患者的生育能力。在这里,我们通过与人类卵巢组织上的常规慢速冷冻方法进行系统比较,来评估玻璃化协议的有效性。方法对每个冷冻保存程序(玻璃化和慢速冷冻)并行处理人卵巢样本(平均年龄28.0±1.1年)。变暖/解冻后,在卵巢卵泡中进行组织学观察和TUNEL测定,并与未冷冻的对照组进行比较。结果两种冷冻保存方案均具有可比的组织学结果。在1.5?M 1,2-丙二醇(PrOH),1.5?M乙二醇(EG)和0.5?M棉子糖溶液中玻璃化后,完整卵泡的百分比为83.6%,在1.5?M中缓慢冷冻后为80.7%。 PrOH和0.025?M棉子糖,新鲜组织中占99.6%。与新鲜组织(0.7个卵囊/ mm2)相比,玻璃化(0.6个卵囊/ mm2)或缓慢冷冻(0.5个卵囊/ mm2)的卵泡密度没有变化。与未冷冻对照(35.0%)相比,在玻璃化(20.8%)或慢速冷冻(31.3%)组织中,带有DNA片段的卵泡百分比没有统计学差异。与未冷冻组织(4.2%)相比,玻璃化组织(6.4%)和慢冻组织(3.7%)中具有DNA片段的基质细胞比例没有差异。结论该玻璃化方案能够在升温后很好地保持卵巢质量。玻璃化后的内分泌功能评估需要在更高的队列中进行,以评估该方案是否可以为冷冻保存人卵巢组织的常规慢速冷冻方法提供相关的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号